Impairment of airway mucociliary transport by Pseudomonas aeruginosa products. Role of oxygen radicals.
We previously showed that the supernatant of a Pseudomonas aeruginosa (PA) culture and its constituents pyocyanin and 1-hydroxyphenazine inhibit ciliary activity of dispersed tracheal epithelial cells in vitro via the generation of oxygen radicals by phagocytes. In the present study, we wished to determine if tracheal mucus velocity (TMV) is also impaired by PA supernatant and if oxygen radicals have a mediating role. In conscious sheep, TMV (measured with a radiographic method) was determined before and serially following aerosol challenge with the cell-free supernatant of a PA culture or unconditioned culture medium (control). TMV decreased from a mean (+/- SEM) baseline of 6.7 +/- 1.1 mm/min (n = 6) by 29, 35, and 25% at 0.5, 3, and 24 h after challenge, respectively (p < 0.05), and returned to baseline 1 wk later (-6%, p = NS). Control medium had no effect on TMV (maximum decrease by 15% at 0.5 h). Aerosolized catalase blunted the effect of PA supernatant on TMV. To determine if the impairment of TMV involved ciliary inhibition, tissues were mounted in a chamber and ciliary beat frequency (CBF) and surface liquid velocity (SLV) were measured with a microscopic method. PA supernatant decreased both CBF (maximum mean decrease 12%; n = 5, p < 0.05) and SLV (maximum mean decrease 78%; n = 5, p < 0.05) in a dose-dependent fashion, with a correlation between the two parameters; these effects were blocked by catalase.(ABSTRACT TRUNCATED AT 250 WORDS)
Seybold
Z V
ZV
Pulmonary Division, University of Miami School of Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140.
Abraham
W M
WM
Gazeroglu
H
H
Wanner
A
A
D000280:Administration, Inhalation; D000818:Animals; D002374:Catalase / Q000008:administration & dosage / Q000502:physiology; D004195:Disease Models, Animal; D005069:Evaluation Studies as Topic; D005260:Female; D005609:Free Radicals / Q000494:pharmacology; D009079:Mucociliary Clearance / Q000187:drug effects*; D010619:Phenazines / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D011550:Pseudomonas aeruginosa / Q000378:metabolism / Q000502:physiology*; D011710:Pyocyanine / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D011859:Radiography; D012756:Sheep; D014132:Trachea / Q000000981:diagnostic imaging / Q000187:drug effects*
D005609:Free Radicals; D010619:Phenazines; C050093:1-hydroxyphenazine; D011710:Pyocyanine; D002374:Catalase